UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000015497
Receipt number R000016572
Scientific Title Exploratory research of the efficacy and safety with the enamel matrix derivative for anterior cruciate ligament reconstruction
Date of disclosure of the study information 2014/10/30
Last modified on 2023/05/24 17:26:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory research of the efficacy and safety with the enamel matrix derivative for anterior cruciate ligament reconstruction

Acronym

Exploratory research of the efficacy and safety with the enamel matrix derivative for anterior cruciate ligament reconstruction

Scientific Title

Exploratory research of the efficacy and safety with the enamel matrix derivative for anterior cruciate ligament reconstruction

Scientific Title:Acronym

Exploratory research of the efficacy and safety with the enamel matrix derivative for anterior cruciate ligament reconstruction

Region

Japan


Condition

Condition

anterior cruciate ligament injury

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Exploratory research of the efficacy and safety with the enamel matrix derivative for anterior cruciate ligament reconstruction

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

KT-2000 measurement of anterior knee laxity at postoperative 2 years

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

At anterior cruciate ligament reconstruction, we will inject enamel matrix derivative (EMDOGAIN 0.3ml) between femoral and tibial bone tunnel and graft. For postoperative 2 years, we will evaluate clinical and radiographic result.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

the patient planed anterior cruciate ligament reconstruction
the patient obtained written informed consent
the patient who can visit a Hiroshima University hospital for treatment for two years

Key exclusion criteria

the patient who apply the contraindication of EMDOGAIN
the patient who cannot obtaine written informed consent and had consciousness disorder or disorientation
the general condition of the patient is considerably bad
the patient with a serious liver damage
the patient with a serious renal damage
the female patient with the possibility with during the pregnancy or pregnancy
the female patient under the nursing
the patient with the past when is allergic to EMDOGAIN
the patient who had perfomed the operation of the knee
in addition, the patient who was disqualified by the chief physician for this study

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Mitsuo
Middle name
Last name Ochi

Organization

Hiroshima University Hospital

Division name

Department of orthopaedic surgery

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima

TEL

082-257-5233

Email

seikei@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Kobun
Middle name
Last name Takazawa

Organization

Hiroshima University Hospital

Division name

Department of orthopaedic surgery

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima

TEL

082-257-5233

Homepage URL


Email

kobuntakazawa@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Center for Integrated Medial Reserch

Address

1-2-3 Kasumi, Minami-ku, Hiroshima

Tel

082-257-1725

Email

protocol@cimr.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 10 Month 30 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085527/pdf/cureus-0015-00000035960.pdf

Number of participants that the trial has enrolled

19

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

It took a long time to prepare the final report.

Date of the first journal publication of results

2023 Year 04 Month 14 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 07 Month 15 Day

Date of IRB

2014 Year 07 Month 15 Day

Anticipated trial start date

2014 Year 10 Month 30 Day

Last follow-up date

2018 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 10 Month 22 Day

Last modified on

2023 Year 05 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016572


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name